Last update 01 Nov 2024

Myriad Therapeutics, Inc.

Private Company

Overview

Related

1
Drugs associated with Myriad Therapeutics, Inc.
MPC-2130
Target
MMPs
Mechanism
MMPs inhibitors [+1]
Active Org.-
Originator Org.
Myrexis, Inc.Myrexis, Inc.
Active Indication-
Inactive Indication
Hematologic Neoplasms [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Myriad Therapeutics, Inc.
NCT00387153 / TerminatedPhase 1
Phase 1 OL, Dose Escalating, Multiple Dose Study To Determine The Safety, Tolerability, MTD, And Pharmacokinetics Of MPC-2130 Administered As Daily IV Infusions For 5 Days, Repeated Every 21 Days, In Patients With Refractory Cancer
100 Clinical Results associated with Myriad Therapeutics, Inc.
Login to view more data
0 Patents (Medical) associated with Myriad Therapeutics, Inc.
Login to view more data
100 Deals associated with Myriad Therapeutics, Inc.
Login to view more data
100 Translational Medicine associated with Myriad Therapeutics, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MPC-2130
 ( MMPs )		Hematologic Neoplasms
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free